MICA and ovarian carcinoma: Early studies have shown that the expression rate of MICA/B and ULBP1-4 is 60–88% in ovarian cancer tissues, while expression of MICA/B and ULBP2-4 is more common in ovarian cancer cell lines [26, 27].